Authors

• Héctor Pinargote‐Celorio (ORCID: https://orcid.org/0000-0002-3300-5807)
• Esperanza Merino (ORCID: https://orcid.org/0000-0003-3854-4874)
• María Dolores Valverde-Fredet (ORCID: https://orcid.org/0009-0009-7079-6634)
• Ana Isabel Aller-García
• Pedro Martínez Pérez-Crespo
• María Paz Ventero (ORCID: https://orcid.org/0000-0003-1979-0949)
• Marta Trigo-Rodríguez (ORCID: https://orcid.org/0000-0003-2880-2024)
• José Manuel Ramos (ORCID: https://orcid.org/0000-0002-6501-9867)
• Joaquín Felipe Lanz-García
• Livia Giner (ORCID: https://orcid.org/0000-0002-1885-3736)
• Nicolás Merchante (ORCID: https://orcid.org/0000-0003-1120-8942)
• Miguel Rodríguez-Fernández (ORCID: https://orcid.org/0000-0001-8028-3722)
• Pilar González-de-la-Aleja (ORCID: https://orcid.org/0000-0001-9360-7394)
• Reinaldo Espíndola-Gómez
• Juan Carlos Rodrı́guez (ORCID: https://orcid.org/0000-0001-8007-5739)
• Rocío Herrero
• Eva León
• Mónica Parra
• Juan E. Corzo (ORCID: https://orcid.org/0000-0001-9687-4009)
• Antonio Fernández-Pevida (ORCID: https://orcid.org/0000-0002-9090-0234)
• Lucía Valiente-De-Santis

Institutions

• Universitat de Miguel Hernández d'Elx (ES)
• Instituto de Biomedicina de Sevilla (ES)
• Hospital General Universitario de Alicante Doctor Balmis (ES)
• Hospital Universitario de Valme (ES)

Publication Details

Journal

Infectious Diseases and Therapy

Published

2025-11-07

DOI

https://doi.org/10.1007/s40121-025-01261-9

Primary Topic

Clostridium difficile and Clostridium perfringens research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• European Commission
• Instituto de Salud Carlos III
• European Regional Development Fund